Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00798_DB01111_nanopub.RA0gzef4Pd2hbgU3nnkborVD5Jb_QDt1SdrJpKY32GkvQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00798_DB01111 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00798_DB01111 label "DDI between Gentamicin and Colistimethate - Aminoglycosides may enhance the nephrotoxic effect of Colistimethate. Aminoglycosides may enhance the neuromuscular-blocking effect of Colistimethate. Due to the potential for additive or synergistic toxicities (including both nephrotoxicity and neuromuscular blockade) between colistimethate and the aminoglycoside antibiotics, this combination should be avoided whenever possible. If these agents must be used together, patients' renal and neuromuscular function should be monitored closely. [drugbank_resource:DB00798_DB01111]" assertion.
- drugbank_resource:DB00798_DB01111 identifier "drugbank_resource:DB00798_DB01111" assertion.
- drugbank_resource:DB00798_DB01111 title "DDI between Gentamicin and Colistimethate - Aminoglycosides may enhance the nephrotoxic effect of Colistimethate. Aminoglycosides may enhance the neuromuscular-blocking effect of Colistimethate. Due to the potential for additive or synergistic toxicities (including both nephrotoxicity and neuromuscular blockade) between colistimethate and the aminoglycoside antibiotics, this combination should be avoided whenever possible. If these agents must be used together, patients' renal and neuromuscular function should be monitored closely." assertion.
- drugbank:DB01111 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00798_DB01111 assertion.
- drugbank:DB00798 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00798_DB01111 assertion.